Biolife Solutions (BLFS) Research & Development (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Research & Development data on file, last reported at $2.5 million in Q1 2026.

• On a quarterly basis, Research & Development rose 75.54% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $10.0 million, a 35.52% increase from a year earlier, with the FY2025 full-year figure at $9.8 million, up 10.28% from the prior year.
• Research & Development for Q1 2026 stood at $2.5 million, up from $2.2 million in the prior quarter.
• Over the last five years, Research & Development for BLFS reached as high as $5.3 million in Q3 2022 and fell as low as -$7.2 million in Q4 2023.
• Historically, Research & Development has averaged $1.8 million across 5 years, with a median of $2.5 million in 2026.
• On a YoY basis, Research & Development climbed as much as 142.01% in 2022 and fell as far as 245.04% in 2022.
• Year by year, Research & Development stood at -$6.9 million in 2022, then decreased by 4.13% to -$7.2 million in 2023, then jumped by 121.7% to $1.6 million in 2024, then jumped by 41.57% to $2.2 million in 2025, then climbed by 13.94% to $2.5 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $2.5 million in Q1 2026, $2.2 million in Q4 2025, and $2.5 million in Q3 2025.